Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hinge HealthHNGE +0.25%12 Debt-to-EBITDA is 0.04 as of Jun. 2026. GuruFocus rates HNGE with a GF Score™ of 12/100. The stock has 7 warning signs investors should review. Among 478 Healthcare Providers & Services companies, Hinge Health ranks better than 94.77% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Hinge Health's Debt-to-EBITDA or its related term are showing as below:
HNGE'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.43 Med: -0.13 Max: 0.06
Current: 0.06
During the past 3 years, the highest Debt-to-EBITDA Ratio of Hinge Health was 0.06. The lowest was -0.43. And the median was -0.13.
HNGE's Debt-to-EBITDA is ranked better than 94.77% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.195
vs HNGE: 0.06
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Hinge Health Debt-to-EBITDA Related Terms
Hinge Health Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Hinge Health's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Hinge Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hinge Health Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hinge Health's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Hinge Health's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Hinge Health (HNGE) has a Debt-to-EBITDA of 0.04 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Hinge Health. According to the industry distribution chart, Hinge Health ranks #25 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 5.2%.
Is Hinge Health's Debt-to-EBITDA too high?
Hinge Health's current Debt-to-EBITDA is 0.04. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.20. Hinge Health's value of 0.04 is 98.2% below this industry median. Based on the distribution chart, Hinge Health ranks #25 out of 478 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Hinge Health has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Hinge Health's Debt-to-EBITDA compare to TXG and WAY?
According to the Healthcare Providers & Services industry distribution chart, Hinge Health ranks #25 out of 478 companies for Debt-to-EBITDA. This places Hinge Health in the top 5% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.20. Hinge Health's value of 0.04 is 98.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.20, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hinge Health's current Debt-to-EBITDA of 0.04 is 98.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Hinge Health. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hinge Health's current Debt-to-EBITDA is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hinge Health stock overvalued right now?
Hinge Health (HNGE) has a current Debt-to-EBITDA of 0.04. The current Debt-to-EBITDA is 0.04 and 98.2% below the Healthcare Providers & Services industry median of 2.20. Hinge Health's overall GF Score™ is 12/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Hinge Health (HNGE), the current Debt-to-EBITDA is 0.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.
12GF Score
Get the complete analysis for HNGE
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HNGE has been successfully added to your 
